We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking LCTX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
LC

Lineage Cell Therapeutics, Inc. (LCTX) short interest & options flow

AMEX

Lineage Cell Therapeutics heads into its May 14 earnings print riding a wall of analyst buy ratings, while the stock itself has quietly slipped 10% over the past month. The analyst community is uniformly bullish — all six covering analysts carry Buy ratings, with a mean price target of $5.14 against a current price of $1.33. Canaccord Genuity initiated coverage on April 28 with a…

$1.11+6.73% 1d+7.77% 1w+11.67% 1mClose: 11 Nov 2026
Short interest % of float
High
Live SI on ORTEX →
Cost to borrow
Low
Live CTB on ORTEX →
Market cap
$281M
Next earnings
12 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 12 Nov 2026

ORTEX chart of Lineage Cell Therapeutics, Inc. (LCTX) share price and short interest (% of free float), six months to November 11, 2026

LCTX news and analysis

RSS

No long-form analysis yet for LCTX. Pulse alerts and the live data picture are available on ORTEX.

Open LCTX on ORTEX →

Want the live picture for LCTX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LCTX — free to start on ORTEX.

Sign up for free →Open LCTX on ORTEX